Market Overview:
The global bio-identical hormones replacement therapy market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hormonal imbalance, rising awareness about the benefits of bio-identical hormones replacement therapy, and technological advancements in this field. The global bio-identical hormones replacement therapy market is segmented on the basis of type into estrogens, progesterone, testosterone, and others. On the basis of application, it is segmented into hospitals, clinics, and others. Geographically it is segmented into North America (U.S., Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) and Middle East & Africa (South Africa).
Product Definition:
Bio-identical hormone replacement therapy (BHRT) is the use of hormones that are identical in chemical structure to those produced by the human body.
The importance of BHRT lies in its ability to provide hormone levels that are more consistent with those found in a healthy person. This can help to improve symptoms and protect against some chronic diseases.
Estrogens:
Estrogens, also known as female hormones or estrogenic substances, are a group of related hormones that regulate the growth and development of the female reproductive system and mammary glands. Estrogen is produced in women by the ovaries. It plays an important role in maintaining bone strength, enhancing memory, regulating the menstrual cycle ( fertility), preventing osteoporosis (brittle bones) during menopause and promoting weight loss.
Progesterone:
Progesterone is a female hormone, which is produced in the ovaries. It is mainly responsible for maintaining the pregnancy. In addition, it has several other functions such as maintenance of corpora lutea (yellowish skin around the vaginal opening), maintenance of endometrial lining of uterus and regulation of menstrual cycle. Progesterone levels decline with advancing age due to lack of production by the adrenal glands and from ovaries.
Application Insights:
The others application segment held the largest share of over 30.0% in 2017. This is due to the increasing use of bio-identical hormones for treating conditions such as acne, osteoporosis, androgenic alopecia, and Cushing¢â‚¬â„¢s syndrome among others. Hospitals are considered to be the major application segment owing to their accessibility and availability of advanced healthcare facilities 24*7*.
The clinics application segment is expected witness lucrative growth during the forecast period owing to growing awareness about hormone replacement therapy among both menopausal women as well as aging men across various countries worldwide. Increasing geriatric population base with respect to both genders coupled with rising cases of health disorders like heart diseases, hypertension, diabetes mellitus etc., are anticipated to boost demand for bio-identical hormones replacement therapies globally in near future.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers, high healthcare expenditure, and favorable government initiatives are some factors contributing to its growth. In 2014, North America accounted for approximately 42% share in terms of revenue due to the growing demand for bio-identical hormones replacement therapy products from U.S., which is one of the most developed countries regarding healthcare infrastructure and technology with well-established distribution channels between various manufacturers/suppliers.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income levels resulting into increased spending on health care by consumers as well as government agencies such as Medicare & Medicaid Services (MMS). Rising awareness about BHRT among patients seeking treatment at private hospitals in countries like India has been driving regional market growth since 2015; however, slow regulatory approval process by FDA coupled with high cost associated with clinical trials may limit this trend during future years.
Growth Factors:
- Increasing awareness about the benefits of bio-identical hormones replacement therapy (BHRT) is driving the market growth.
- Growing geriatric population is also a major factor that is contributing to the growth of this market as they are more prone to hormonal imbalances and other health conditions that can be treated with BHRT.
- Rising prevalence of chronic diseases such as obesity, diabetes, and heart diseases has increased the demand for BHRT as these conditions can be effectively managed with its help.
- increasing number of women who are opting for preventive measures to maintain their health in order to enjoy a better quality life in their later years is also propelling the growth of this market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Bio-identical Hormones Replacement Therapy Market Research Report
By Type
Estrogens, Progesterone, Testosterone, Others
By Application
Hospitals, Clinics, Others
By Companies
Advantage Pharmaceuticals, Full Life Wellness Center, Neuv Aesthetics, SottoPelle, BioTE Medical, Defy Medical, Biostation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Bio-identical Hormones Replacement Therapy Market Report Segments:
The global Bio-identical Hormones Replacement Therapy market is segmented on the basis of:
Types
Estrogens, Progesterone, Testosterone, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advantage Pharmaceuticals
- Full Life Wellness Center
- Neuv Aesthetics
- SottoPelle
- BioTE Medical
- Defy Medical
- Biostation
Highlights of The Bio-identical Hormones Replacement Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Estrogens
- Progesterone
- Testosterone
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bio-identical Hormones Replacement Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bio-identical hormones replacement therapy is a treatment for hormone deficiencies that uses natural, identical hormones made from the same ingredients as the body's own hormones. Bio-identical hormones are not only more effective than traditional hormone replacement therapy (THR), but they also have fewer side effects.
Some of the major players in the bio-identical hormones replacement therapy market are Advantage Pharmaceuticals, Full Life Wellness Center, Neuv Aesthetics, SottoPelle, BioTE Medical, Defy Medical, Biostation.
The bio-identical hormones replacement therapy market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bio-identical Hormones Replacement Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bio-identical Hormones Replacement Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bio-identical Hormones Replacement Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bio-identical Hormones Replacement Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bio-identical Hormones Replacement Therapy Market Size & Forecast, 2018-2028
4.5.1 Bio-identical Hormones Replacement Therapy Market Size and Y-o-Y Growth
4.5.2 Bio-identical Hormones Replacement Therapy Market Absolute $ Opportunity
Chapter 5 Global Bio-identical Hormones Replacement Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bio-identical Hormones Replacement Therapy Market Size Forecast by Type
5.2.1 Estrogens
5.2.2 Progesterone
5.2.3 Testosterone
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bio-identical Hormones Replacement Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bio-identical Hormones Replacement Therapy Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bio-identical Hormones Replacement Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bio-identical Hormones Replacement Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bio-identical Hormones Replacement Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Bio-identical Hormones Replacement Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bio-identical Hormones Replacement Therapy Market Size Forecast by Type
9.6.1 Estrogens
9.6.2 Progesterone
9.6.3 Testosterone
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bio-identical Hormones Replacement Therapy Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bio-identical Hormones Replacement Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Bio-identical Hormones Replacement Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bio-identical Hormones Replacement Therapy Market Size Forecast by Type
10.6.1 Estrogens
10.6.2 Progesterone
10.6.3 Testosterone
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bio-identical Hormones Replacement Therapy Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bio-identical Hormones Replacement Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bio-identical Hormones Replacement Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bio-identical Hormones Replacement Therapy Market Size Forecast by Type
11.6.1 Estrogens
11.6.2 Progesterone
11.6.3 Testosterone
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bio-identical Hormones Replacement Therapy Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bio-identical Hormones Replacement Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Bio-identical Hormones Replacement Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bio-identical Hormones Replacement Therapy Market Size Forecast by Type
12.6.1 Estrogens
12.6.2 Progesterone
12.6.3 Testosterone
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bio-identical Hormones Replacement Therapy Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bio-identical Hormones Replacement Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bio-identical Hormones Replacement Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bio-identical Hormones Replacement Therapy Market Size Forecast by Type
13.6.1 Estrogens
13.6.2 Progesterone
13.6.3 Testosterone
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bio-identical Hormones Replacement Therapy Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bio-identical Hormones Replacement Therapy Market: Competitive Dashboard
14.2 Global Bio-identical Hormones Replacement Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Advantage Pharmaceuticals
14.3.2 Full Life Wellness Center
14.3.3 Neuv Aesthetics
14.3.4 SottoPelle
14.3.5 BioTE Medical
14.3.6 Defy Medical
14.3.7 Biostation
